Caitong International Asset Management Co., Ltd
Position in PACB — Pacific Biosciences Of California, Inc.
CIK 1963355
HONG KONG, K3
Position in PACB
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$70,383
+$65,951 QoQ
Shares Held
41,895
+1147.6% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#31
of 81 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PACB Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Caitong International Asset Management Co., Ltd holds $2,025,531 across 72 Medical Devices names. PACB ranks #7 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
10,214 | $435,933 | |
| 2 | ATEC |
Alphatec Holdings, Inc.
|
45,692 | $395,235 | |
| 3 | TNDM |
Tandem Diabetes Care Inc
|
19,968 | $301,317 | |
| 4 | SNN |
Smith & Nephew PLC
|
6,056 | $174,473 | |
| 5 | PHG |
Koninklijke Philips NV
|
5,820 | $158,245 | |
| 6 | DXCM |
Dexcom Inc
|
1,485 | $100,014 | |
| 7 | PACB |
Pacific Biosciences Of California, Inc.
This page
|
41,895 | $70,383 | |
| 8 | STIM |
Neuronetics, Inc.
|
41,320 | $53,716 |
All Filings in PACB
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,383 | 41,895 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $4,432 | 3,358 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $19,393 | 10,371 | Shares | Sole | 2026-03-04 | |
| 2025-09-30 | $29,153 | 22,776 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $2,849 | 2,298 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $19,704 | 16,699 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||